Read more

April 20, 2024
2 min watch
Save

VIDEO: AccuraSee intraocular pseudophakic contact lens investigated in AMD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Kevin J. Cady of OnPoint Vision provides an update on the AccuraSee intraocular pseudophakic contact lens.

The idea behind the lens is to fine-tune refractive error in patients who have already undergone cataract surgery, but the first-generation model addresses age-related macular degeneration, with the company entering into a phase 1 trial.

“The outcomes are looking promising,” Cady said. “We are gaining five to six lines of vision for patients, essentially, you could categorize as going blind. Patients are now able to achieve somewhat functional vision for the first time in a long time with the new lens implant.”